Impel Pharmaceuticals Inc. IMPL
Trading inactive
| Déclarant | Citoyenneté ou lieu d'organisation | Pouvoir de vote unique | Pouvoir de vote partagé | Pouvoir de disposition unique | Pouvoir de disposition partagé | Montant en propriété effective | Pourcentage détenu | Date d'achat |
|---|---|---|---|---|---|---|---|---|
| NVP Associates, LLC | Delaware | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Jon E. Kossow | United States America | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Jeffrey Crowe | United States America | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Promod Haque | United States America | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| NVP Associates, LLC | Delaware | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Genesis VC Partners XIV, LLC | Delaware | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Norwest Venture Partners XIV, LP | Delaware | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Norwest Venture Partners XIV, LP | Delaware | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Genesis VC Partners XIV, LLC | Delaware | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Jon E. Kossow | United States America | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Jeffrey Crowe | United States America | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Promod Haque | United States America | 3077198 | 0 | 3077198 | 0 | 3077198 | 13.81 % | 10/08/2021 |
| Dr. Scott M. Rocklage | 2309791 | 11.9 % | 07/05/2021 | |||||
| Andrew J. Schwab | 2884791 | 14.9 % | 07/05/2021 | |||||
| Dr. Kush Parmar | 2884791 | 14.9 % | 07/05/2021 | |||||
| 5AM Partners V, LLC | 2309791 | 11.9 % | 07/05/2021 | |||||
| 5AM Opportunities I, L.P. | 575000 | 3 % | 07/05/2021 | |||||
| 5AM Opportunities I (GP), LLC | 575000 | 3 % | 07/05/2021 | |||||
| Dr. Scott M. Rocklage | 2309791 | 11.9 % | 07/05/2021 | |||||
| 5AM Partners V, LLC | 2309791 | 11.9 % | 07/05/2021 | |||||
| 5AM Opportunities I, L.P. | 575000 | 3 % | 07/05/2021 | |||||
| 5AM Ventures V, L.P. | 2309791 | 11.9 % | 07/05/2021 | |||||
| 5AM Opportunities I (GP), LLC | 575000 | 3 % | 07/05/2021 | |||||
| Andrew J. Schwab | 2884791 | 14.9 % | 07/05/2021 | |||||
| Dr. Kush Parmar | 2884791 | 14.9 % | 07/05/2021 | |||||
| 5AM Ventures V, L.P. | 2309791 | 11.9 % | 07/05/2021 | |||||
| Corey Goodman | United States | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| Robert Adelman | United States | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| venBio Global Strategic GP II, Ltd. | Cayman Islands | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| venBio Global Strategic GP II, L.P. | Cayman Islands | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| venBio Global Strategic Fund II, L.P. | Cayman Islands | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| venBio Global Strategic GP II, L.P. | Cayman Islands | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| venBio Global Strategic Fund II, L.P. | Cayman Islands | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| Corey Goodman | United States | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| Robert Adelman | United States | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| venBio Global Strategic GP II, Ltd. | Cayman Islands | 0 | 2759791 | 0 | 2759791 | 2759791 | 14.2 % | 07/05/2021 |
| Vivo Capital VIII, LLC | Delaware | 2884789 | 0 | 2884789 | 0 | 2884789 | 14.9 % | 06/05/2021 |
| Vivo Capital VIII, LLC | Delaware | 2884789 | 0 | 2884789 | 0 | 2884789 | 14.9 % | 06/05/2021 |